160 related articles for article (PubMed ID: 30187159)
1. Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI,
Cambron M; Reynders T; Debruyne J; Reyngoudt H; Ribbens A; Achten E; Laureys G
J Neurol; 2018 Nov; 265(11):2614-2624. PubMed ID: 30187159
[TBL] [Abstract][Full Text] [Related]
2. Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study.
Schwartzbach CJ; Grove RA; Brown R; Tompson D; Then Bergh F; Arnold DL
J Neurol; 2017 Feb; 264(2):304-315. PubMed ID: 27888416
[TBL] [Abstract][Full Text] [Related]
3. Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
Wiebenga OT; Klauser AM; Schoonheim MM; Nagtegaal GJ; Steenwijk MD; van Rossum JA; Polman CH; Barkhof F; Pouwels PJ; Geurts JJ
AJNR Am J Neuroradiol; 2015 Jun; 36(6):1116-23. PubMed ID: 25742985
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J;
J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109
[TBL] [Abstract][Full Text] [Related]
5. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Nourbakhsh B; Azevedo C; Maghzi AH; Spain R; Pelletier D; Waubant E
J Neurol Sci; 2016 Jul; 366():229-233. PubMed ID: 27288812
[TBL] [Abstract][Full Text] [Related]
6. Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain
Donadieu M; Le Fur Y; Maarouf A; Gherib S; Ridley B; Pini L; Rapacchi S; Confort-Gouny S; Guye M; Schad LR; Maudsley AA; Pelletier J; Audoin B; Zaaraoui W; Ranjeva JP
Mult Scler; 2019 Jan; 25(1):39-47. PubMed ID: 29064346
[TBL] [Abstract][Full Text] [Related]
7. Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging.
Sijens PE; Mostert JP; Irwan R; Potze JH; Oudkerk M; De Keyser J
Psychiatry Res; 2008 Dec; 164(3):274-82. PubMed ID: 19017554
[TBL] [Abstract][Full Text] [Related]
8. Correlation between the corpus callosum index and brain atrophy, lesion load, and cognitive dysfunction in multiple sclerosis.
Gonçalves LI; Dos Passos GR; Conzatti LP; Burger JLP; Tomasi GH; Zandoná MÉ; Azambuja LS; Gomes I; Franco A; Sato DK; Becker J
Mult Scler Relat Disord; 2018 Feb; 20():154-158. PubMed ID: 29414290
[TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O
Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763
[TBL] [Abstract][Full Text] [Related]
10. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
[TBL] [Abstract][Full Text] [Related]
11. Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.
Harper DG; Jensen JE; Ravichandran C; Perlis RH; Fava M; Renshaw PF; Iosifescu DV
Neuropsychopharmacology; 2017 Mar; 42(4):876-885. PubMed ID: 27585738
[TBL] [Abstract][Full Text] [Related]
12. The role of global and regional gray matter volume decrease in multiple sclerosis.
Grothe M; Lotze M; Langner S; Dressel A
J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
[TBL] [Abstract][Full Text] [Related]
13. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
14. Brain levels of high-energy phosphate metabolites and executive function in geriatric depression.
Harper DG; Joe EB; Jensen JE; Ravichandran C; Forester BP
Int J Geriatr Psychiatry; 2016 Nov; 31(11):1241-1249. PubMed ID: 26891040
[TBL] [Abstract][Full Text] [Related]
15. Brain structural changes in patients in the early stages of multiple sclerosis with depression.
Rojas JI; Sanchez F; Patrucco L; Miguez J; Besada C; Cristiano E
Neurol Res; 2017 Jul; 39(7):596-600. PubMed ID: 28245725
[TBL] [Abstract][Full Text] [Related]
16. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant?
Barkhof F; Hulst HE; Drulovic J; Uitdehaag BM; Matsuda K; Landin R;
Neurology; 2010 Mar; 74(13):1033-40. PubMed ID: 20200338
[TBL] [Abstract][Full Text] [Related]
17. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.
Cambron M; Mostert J; Haentjens P; D'Hooghe M; Nagels G; Willekens B; Heersema D; Debruyne J; Van Hecke W; Algoed L; De Klippel N; Fosselle E; Laureys G; Merckx H; Van Wijmeersch B; Vanopdenbosch L; Verhagen W; Hupperts R; Hengstman G; Michiels V; Van Merhaegen-Wieleman A; De Keyser J
Trials; 2014 Jan; 15():37. PubMed ID: 24460863
[TBL] [Abstract][Full Text] [Related]
19. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
[TBL] [Abstract][Full Text] [Related]
20. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
